看多

Clovis Oncology - Possible bottoming formation

355
CLVS has been beat up for a loooong time.

On a 3 hr chart it appears that we are seeing a bottoming inver H&S formation. Company also is making positive news about Rubraca that just met the primary endpoint of significantly improving Progression-Free Survival vs. Chemotherapy.

Completely a momentum based trade with a tight stop loss.

PS Never ever take any of my posts as financial advice.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。